학술논문
Clinical gamma-secretase inhibitors (GSIs) alter beta-amyloid 40/42 ratio in brain and show CSF beta-amyloid rebound in vivo
Document Type
Abstract
Author
Source
In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2013 9(4) Supplement:P806-P807
Subject
Language
ISSN
1552-5260